Steven Copenhaver, M.D.

Associate Professor

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: Texas A & M University College of Medicine (1989)
Internship: Duke University Medical Center (1990), Pediatrics
Residency: Duke University Medical Center (1992), Pediatrics
Fellowship: University of Colorado Health Sciences Center (1996), Pediatric Pulmonology

Research Interest

Publications

Featured Publications

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.: Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW J. Pediatr. 2016 Feb 169 116-21.e2
Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study.: Wojtczak HA, Kerby GS, Wagener JS, Copenhaver SC, Gotlin RW, Riches DW, Accurso FJ Pediatr. Pulmonol. 2001 Oct 32 4 293-302
Cystic Fibrosis: a case of "faded genes": Browne BA, Brunner LJ, Weir MR, Copenhaver, SC Journal of Clinical Problem Based Learning 2000 May
Early inflammation and the development of pulmonary disease in cystic fibrosis.: Wagener JS, Kahn TZ, Copenhaver SC, Accurso FJ Pediatr Pulmonol Suppl 1997 16 267-8
Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.: Kirchner KK, Wagener JS, Khan TZ, Copenhaver SC, Accurso FJ Am. J. Respir. Crit. Care Med. 1996 Nov 154 5 1426-9

Honors & Awards